Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial. (Record no. 15977724)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01486 a2200421 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515011235.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200606s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1538-4047 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.4161/cbt.5.2.2334 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ramos, Tania Crombet |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20060622 |
| 245 00 - TITLE STATEMENT | |
| Title | Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer biology & therapy |
| Date of publication, distribution, etc. | Feb 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 145-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer Vaccines |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
| General subdivision | therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Epidermal Growth Factor |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunotherapy, Active |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vinageras, Elia Neninger |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ferrer, Mauricio Catalá |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Verdecia, Beatriz García |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rupalé, Idrissa Leonard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pérez, Liana Martínez |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marinello, Gisela González |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rodríguez, Rolando Pérez |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dávila, Agustín Lage |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer biology & therapy |
| Related parts | vol. 5 |
| -- | no. 2 |
| -- | p. 145-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.4161/cbt.5.2.2334">https://doi.org/10.4161/cbt.5.2.2334</a> |
| Public note | Available from publisher's website |
No items available.